D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients : D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in SARS-COV-2 Patients: A Retrospective Study
Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
ClinicalTrials.gov - (2022) vom: 15. März Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: March 15, 2022, Last downloaded: ClinicalTrials.gov processed this data on March 28, 2022, Last updated: March 30, 2022 |
|---|
| Study ID: |
NCT05279469 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG008266220 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG008266220 | ||
| 003 | DE-627 | ||
| 005 | 20230425193641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220316s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG008266220 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT05279469 | ||
| 035 | |a (UBBS_Klinische_Studien)MS56/2022 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients |b D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in SARS-COV-2 Patients: A Retrospective Study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: March 15, 2022, Last downloaded: ClinicalTrials.gov processed this data on March 28, 2022, Last updated: March 30, 2022 | ||
| 520 | |a Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease. | ||
| 650 | 2 | |a Pneumonia, Viral | |
| 650 | 2 | |a Critical Illness | |
| 650 | 4 | |a Medical Condition: Critical Illness, Pneumonia, Viral | |
| 650 | 4 | |a Study Type: Observational | |
| 650 | 4 | |a Recruitment Status: Completed | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2022) vom: 15. März |
| 773 | 1 | 8 | |g year:2022 |g day:15 |g month:03 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT05279469 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 15 |c 03 | ||